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The ubiquinol:cytochrome c reductase activity of Puracentrotus lividus mitochondria is relatively insensitive to the specific inhibitors myxothiazol 
and mucidin. The Is0 of myxothiazol and mucidin are three and two orders of magnitude higher, respectively, in P. lividus than in bovine heart 
mitochondria. The natural resistance of the P. lividus reductase to these inhibitors can be correlated with a single amino replacement, an alanine 
for a glycine at position 143, in the sequence of cytochrome b. This position is located in a conserved region of the molecule, believed to be important 
in the oxidation of ubiquinol by the reductase. 
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1. INTRODUCTION 
Dihaem cytochrome b of the ubiquinol : cytochrome 
c reductase (cytochrome bci complex) is now among 
the best characterized membrane proteins [l-3]. The 
knowledge of this cytochrome has expanded greatly 
due to the availability of two classes of inhibitors that 
specifically interact with one or other of the two redox 
centres of the protein, centre ‘i’ and centre ‘0’ accor- 
ding to the Q-cycle scheme [3-51. 
natural resistance towards inhibitors that bind to 
cytochrome b may be present in some species. Here we 
report that the ubiquinol:cytochrome c reductase in 
mitochondria of the sea urchin Paracentrotus lividus is 
naturally resistant to the centre ‘0’ inhibitors myx- 
othiazol and mucidin. 
2. MATERIALS AND METHODS 
Structure-function correlations have been made 
possible by the determination of the sequence of several 
mutants of cytochrome b that are resistant to either 
centre ‘i’ or centre ‘0’ inhibitors [3,6-121. These 
mutants generally possess a single amino acid replace- 
ment that strongly decreases the inhibitors’ potency 
either in vivo or in vitro [6-8,10-121. It is widely 
recognized that the positions conferring inhibitor 
resistance in cytochrome b are either close to one of its 
redox centres or constitute parts of its ubiquinol/ubi- 
quinone binding sites [3,8,10,12]. In particular, most of 
the mutations conferring resistance to centre ‘0’ in- 
hibitors map within a highly conserved region of 
cytochrome b that is located between the third and the 
fourth transmembrane helices in the current models 
[2,3,7,8,10,12]. 
Bovine (Bos taunts) heart mitochondria and P. lividus egg 
mitochondria were prepared according to [13] and [14], respectively. 
The cytochrome b content of the mitochondria was measured by the 
reduced minus oxidized difference spectrum at 560-575 nm using an 
extinction coefficient of 25 mM_’ cm-‘. Ubiquinols were prepared as 
in [15]. Ubiquinone-2 was a generous gift of Eisai Co., Tokyo, Japan 
and 2,3-dimethoxy-5-methyl-6-nonyl benzoquinone was donated by 
Professor Cl. Von Jagow, University of Frankfurt, FRG. Myx- 
othiazol was purchased from Boehringer and mucidin was kindly 
provided by Dr J. Subik, University of Bratislava, Czechoslovakia. 
The concentration of the inhibitors in ethanol was measured as in [5]. 
Ubiquinol :cytochrome c reductase was assayed as described in [ 161. 
3. RESULTS 
Amino acid replacements that are similar to those 
found in resistant mutants can be deduced also from 
the comparison of the various sequences of cytochrome 
b which are now available [7-121. This suggests that 
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The highly conserved region spanning residues 
128-150 (using yeast as the reference [2,3,8]) in the se- 
quence of cytochrome b is believed to form an impor- 
tant portion of the binding pocket of centre ‘0’ 
inhibitors [3,8,10,12]. This region contains 8 of the ap- 
proximately 30 invariant residues present in the 
mitochondrial and bacterial sequences examined 
(Fig. 1 and [17]). As shown in Fig. 1, the sequence of 
cytochrome b from P. fividus mitochondria [ 181 has the 
single amino acid replacement of a highly conserved 
glycine by an alanine at position 143. The same 
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SPECIES AMINO ACID SEQUENCE 
130 140 150 
Saccharomyces cerevisiae AFLGYCCVYGQMSHWGATVITNL 
60s taurus AFMGYVLPWGQMSFWGATVITNL 
Rhodobacter capsulatus AFMGYVLPWGQMSFWGATVITGL 
Paracentrotus lividus AFWGYVLVWGQMSFWAATVITNL 
J 
CONSENSUS 
(mitochondria and bacteria) 
A;MGY"LPW;QMSFWG*ATVITNL -- .- -..-.. . 
Fig. 1. Alignment of some phylogenetically-representative sequences 
of cytochrome b of ubiquinol : cytochrome c reductase. The 4 upper 
sequences are aligned to that of S. cerevisiae [2,3] and are 
representative of yeasts, mammals, bacteria and sea urchins. In the 
consensus of bacterial and mitochondrial sequences (taken from 
those listed in [2,3,8,10,12,17-191) shown below, the apparently 
invariant residues are underlined, the residues that are conserved in 
all but one or two species are indicated by dots and the positions at 
which resistance to myxothiazol and mucidin occurs [8,10,12] are 
marked by asterisks. This protein region is believed to contain the C- 
terminal part of the third transmembrane helix (up to ca. position 
135) and an amphipathic loop that was previously predicted to span 
the membrane [2,3,7-lo]. The sequence of P. lividus, the numeration 
of which is identical to that of yeast in the region shown [17,18], 
differs slightly from that previously published [IS]. Further cloning 
and DNA sequencing revealed that positions 138 and 148 are Q and 
T rather than R and A, respectively. The assignment of A at position 
143 (indicated by the arrow) was confirmed by many independent 
sequencing data. 
substitution is observed only in another sea urchin 
cytochrome b [19] and is remarkable for it is identical, 
even in the base exchange (G-C at the second position 
of the codon [ 18]), to that found in mouse and bacterial 
A 
mutants showing resistance to the centre ‘0’ inhibitors 
myxothiazol and mucidin [ 10,121. 
This observation strongly suggests that P. lividus 
mitochondria may have an ubiquinol: cytochrome c 
reductase activity less sensitive to myxothiazol and 
mucidin than, for instance, mammalian mitochondria. 
Indeed, this is the case, as shown in Fig. 2. The in- 
hibitor titre of myxothiazol is three orders of 
magnitude higher in P. lividus than in bovine heart 
mitochondria, the 150 being 4.0 x 10e6 M instead of 5.6 
x 10e9 M (Fig. 2A). A large increase in the inhibitor 
titre is also seen for mucidin, since its Iso is 2.8 x 
1O-6 M in P. lividus mitochondria whereas it is 3.2 x 
10e8 M in bovine heart mitochondria (Fig. 2B). The 
latter value is almost identical to the Ki of 30 nM 
measured under similar conditions with the reductase 
complex purified from bovine heart [20]. 
4. DISCUSSION 
Herein we report the first example of a mitochon- 
drial ubiquinol : cytochrome c reductase that is natural- 
ly resistant o myxothiazol and mucidin, two powerful 
centre ‘0’ inhibitors [5]. The increased titres of the in- 
hibitors of P. lividus as compared with bovine heart are 
similar to those measured in resistant mutants of mouse 
with respect o their wild-type [IO]. Interestingly, myx- 
othiazol is somewhat less efficient than mucidin in P. 
lividus mitochondria (Fig. 2). By contrast, in all other 
species myxothiazol binds one order of magnitude 
more tightly than mucidin [5,8,12,20]. 
It is highly probable that the decrease in potency of 
myxothiazol and mucidin in the P. lividus reductase 
.B 
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log [inhibitor] (M) 
I 
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Fig. 2. Comparative inhibition of the ubiquinol: cytochrome c reductase by myxothiazol and mucidin in bovine heart and P. lividus mitochondria. 
(A) Myxothiazol titration of ubiquinol-2 (10 PM): cytochrome c (20 ,uM) reductase, assayed with mitochondria containing 4 and 7 nM cytochrome 
b of bovine heart and P. lividus, respectively. The uninhibited turnover of the reductase was 384 s -I in bovine and 118 SK’ in P. lividus. (B) 
Mucidin titration of 2,3-dimethoxy-5-methyl-6-nonyl benzoquinol(5 PM): cytochrome c reductase assayed as in A, but with different preparations 
of both mitochondria. The uninhibited rate was 230 s-t in bovine heart and 75 s-’ in P. lividus. Note that the reductase activity in P. lividus 
is as sensitive to antimycin as that in bovine mitochondria under the above conditions. 
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(Fig, 2) is primarily derived from amino acid substitu- 
tions in the sequence of its cytochrome b (see also 
[1,3,5-12,201 for supporting evidence). The only 
significant residue change, with respect to species that 
are normally very sensitive to these inhibitors (e.g. 
yeast), is the replacement of the otherwise highly con- 
served glycine by an alanine at position 143 (Fig. 1, cf. 
[1,3,8,12,18]). This can be considered as the major 
molecular reason for the resistance to these inhibitors 
in P. lividus cytochrome b. The introduction of a 
methyl group in the glycine to alanine substitution 
presumably causes steric hindrance, preventing full 
recognition of myxothiazol and mucidin. 
Myxothiazol differs from mucidin in the structure 
and volume of its hydrophobic tail, since both in- 
hibitors possess a similar methoxyacrylate group [S]. 
The loss of steric recognition of such compounds that 
function as ubiquinol antagonists [5,20], therefore, 
suggests that position 143 of cytochrome b could be in- 
volved in the specific binding of the polyisoprenoid tail 
of ubiquinol at centre ‘0’. Preliminary experiments of 
steady-state activity (M. Degli Esposti, unpublished 
results) support this idea, since in P. lividus mitochon- 
dria the relative affinity for ubiquinol homologues and 
analogues appears to be different from that in other 
mitochondria. Further studies are under way to clarify 
this point. 
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